Apogee Therapeutics

Apogee Therapeutics is a clinical-stage biotechnology company dedicated to developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma, and other inflammatory and immune-related indications with significant unmet needs. Apogee's antibody programs aim to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering features to optimize half-life and other properties.